Intermittent fasting

Authors

  • A.A. Paltsyn Scientific Research Institute of General Pathology and Pathophysiology, 8 Baltiyskaya Str., Moscow, 125315, Russian Federation; Russian Medical Academy of Postgraduate Education, Moscow 125315, Russian Federation
  • N.B. Sviridkina Scientific Research Institute of General Pathology and Pathophysiology, 8 Baltiyskaya Str., Moscow, 125315, Russian Federation

DOI:

https://doi.org/10.25557/0031-2991.2021.04.116-120

Keywords:

obesity, therapeutic fasting, ketone bodies, intestinal microbiota

Abstract

Intermittent fasting is a method for prevention and treatment of the currently most common pathology, overweight and obesity. Of particular relevance is the fact that ugly and life-complicating obesity is a marker of metabolic disorders that predispose people to many noninfectious pandemics. The interval fasting is performed by daily complete refraining from food for at least 12 hours with a 12h:12h ratio of fasting and food consumption periods. Increasing the fasting period, for example to 18h:6h, enhances the preventive and therapeutic efficacy of intermittent fasting.

Downloads

Published

2021-12-20

Issue

Vol. 65 No. 4 (2021)

Section

Reviews

How to Cite

[1]
2021. Intermittent fasting. Patologicheskaya Fiziologiya i Eksperimental’naya Terapiya (Pathological physiology and experimental therapy). 65, 4 (Dec. 2021), 116–120. DOI:https://doi.org/10.25557/0031-2991.2021.04.116-120.

Most read articles by the same author(s)